345 results on '"Lenihan, Daniel"'
Search Results
2. Age- and Sex-Related Differences in Patients With Wild-Type Transthyretin Amyloidosis: Insights From THAOS
3. Cardioprotective Potential of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Cancer Treated With Anthracyclines: An Observational Study
4. Late cardiac events after allogeneic stem cell transplant: incidence, risk factors, and impact on overall survival
5. Clinicopathological classification of immune checkpoint inhibitor-associated myocarditis: possible refinement by measuring macrophage abundance
6. Incidental Coronary Arterial Calcification for Cardiovascular Risk Assessment in Men With Prostate Cancer Undergoing PET/CT Imaging
7. Cardio-Oncology and Heart Failure: a Scientific Statement From the Heart Failure Society of America
8. SGLT2 Inhibitor Use and Risk of Clinical Events in Patients With Cancer Therapy–Related Cardiac Dysfunction
9. Real-World Efficacy of Tafamidis in Patients With Transthyretin Amyloidosis and Heart Failure
10. Permissive Cardiotoxicity: The Clinical Crucible of Cardio-Oncology
11. Clinical Practice Guidelines in Cardio-Oncology
12. Future Developments in Light Chain Amyloidosis Management
13. Developing Therapy for Transthyretin Amyloidosis
14. The right heart in patients with cancer. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio‐Oncology.
15. How to utilize current guidelines to manage patients with cancer at high risk for heart failure.
16. Relationship between quality of life indicators and cardiac status indicators in chemotherapy patients
17. Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey
18. Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis: Insights From THAOS
19. How to Manage Patients With Cardiac Implantable Electronic Devices Undergoing Radiation Therapy
20. Cardiovascular Manifestations From Therapeutic Radiation: A Multidisciplinary Expert Consensus Statement From the International Cardio-Oncology Society
21. Clinical Approach to Cardiovascular Toxicity of Oral Antineoplastic Agents: JACC State-of-the-Art Review
22. Cardiac Amyloidosis for the Primary Care Provider: A Practical Review to Promote Earlier Recognition of Disease
23. Management of Patients With Giant Cell Myocarditis: JACC Review Topic of the Week
24. Cardiac Biomarkers During Cancer Therapy: Practical Applications for Cardio-Oncology
25. Differential Expression of Circulating miRNAs and Carfilzomib-Related Cardiovascular Adverse Events in Patients with Multiple Myeloma.
26. Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) Pandemic
27. Plasma Hepatocyte Growth Factor for Diagnosis and Prognosis in Light Chain and Transthyretin Cardiac Amyloidosis
28. Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure: The 3T Trial
29. Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart: JACC Council Perspectives
30. Proceedings From the Global Cardio-Oncology Summit: The Top 10 Priorities to Actualize for CardioOncology
31. A Unique Case of Orthostasis in a Patient With Testicular Choriocarcinoma
32. Anthracycline Cardiotoxicity: It Is Possible to Teach an Old Dog Some New Tricks
33. Cardiovascular Toxicities of Immune Checkpoint Inhibitors: JACC Review Topic of the Week
34. Hypertension in the Cardio-Oncology Clinic
35. Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis
36. Preparing the Cardiovascular Workforce to Care for Oncology Patients: JACC Review Topic of the Week
37. Metabolomic signatures of carfilzomib‐related cardiotoxicity in patients with multiple myeloma.
38. Management of Cancer Therapeutics–Related Cardiac Dysfunction
39. Customizing national models for a medical center's population to rapidly identify patients at high risk of 30-day all-cause hospital readmission following a heart failure hospitalization
40. Introduction to ‘Proceedings from Amyloidosis, A Hidden Disease with a Bright Future: A Multi-Disciplinary Approach to Diagnosis and Management of Amyloidosis’
41. Clinical utility of single molecule counting technology for quantification of KIM-1 in patients with heart failure and chronic kidney disease
42. Elevated Cardiovascular Disease Risk in Patients With Chronic Myelogenous Leukemia Seen in Community-based Oncology Practices in the United States
43. Outcomes from Autologous Hematopoietic Cell Transplantation versus Chemotherapy Alone for the Management of Light Chain Amyloidosis
44. Current Concepts of Cardiac Amyloidosis: Diagnosis, Clinical Management, and the Need for Collaboration
45. A Phase I, Single Ascending Dose Study of Cimaglermin Alfa (Neuregulin 1β3) in Patients With Systolic Dysfunction and Heart Failure
46. Clinical and Research Considerations for Patients With Hypertensive Acute Heart Failure: A Consensus Statement from the Society of Academic Emergency Medicine and the Heart Failure Society of America Acute Heart Failure Working Group
47. Cardio-Oncology Training: A Proposal From the International Cardioncology Society and Canadian Cardiac Oncology Network for a New Multidisciplinary Specialty
48. The Utility of Point-of-Care Biomarkers to Detect Cardiotoxicity During Anthracycline Chemotherapy: A Feasibility Study
49. Getting the SCOOP—Survey of Cardiovascular Outcomes From Oncology Patients During Survivorship
50. Heart Failure With Preserved Left Ventricular Function: Diagnostic and Therapeutic Challenges in Patients With Diastolic Heart Failure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.